New Delivery Methods for Established Migraine Drugs Are on the Horizon

Neurology Reviews. 2013 June;21(6):19

July 11, 2013|Neurology

—Erik Greb
Senior Associate Editor

Suggested Reading
Djupesland PG, Docekal P; Czech Migraine Investigators Group. Intranasal sumatriptan powder delivered by a novel breath-actuated bi-directional device for the acute treatment of migraine: A randomised, placebo-controlled study. Cephalalgia. 2010;30(8):933-942.

Rapoport AM. The therapeutic future in headache. Neurol Sci. 2012;33(Suppl 1):S119-S125.

Schoenen J, Jensen RH, Lantéri-Minet M, et al. Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: A randomized, sham-controlled study. Cephalalgia. 2013 Feb 14 [Epub ahead of print].

Shrewsbury SB, Cook RO, Taylor G, et al. Safety and pharmacokinetics of dihydroergotamine mesylate administered via a novel (Tempo) inhaler. Headache. 2008;48(3):355-367.